Integra LifeSciences Holdings Corp (IART) - Product Pipeline Analysis, 2017 Update

Summary

Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integras orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The companys neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Integra LifeSciences Holdings Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Integra LifeSciences Holdings Corp Company Overview 6
Integra LifeSciences Holdings Corp Company Snapshot 6
Integra LifeSciences Holdings Corp Pipeline Products and Ongoing Clinical Trials Overview 6
Integra LifeSciences Holdings Corp Pipeline Analysis Overview 9
Business Description 9
Integra LifeSciences Holdings Corp - Key Facts 9
Integra LifeSciences Holdings Corp - Major Products and Services 10
Integra LifeSciences Holdings Corp Pipeline Products by Development Stage 13
Integra LifeSciences Holdings Corp Pipeline Products Overview 15
2-Piece Total Ankle Replacement System 15
2-Piece Total Ankle Replacement System Product Overview 15
Abdominal Wall Matrix 16
Abdominal Wall Matrix Product Overview 16
Advanced Glenoid Platform 17
Advanced Glenoid Platform Product Overview 17
Advanced Shoulder System 18
Advanced Shoulder System Product Overview 18
Biologic Vascular Graft 19
Biologic Vascular Graft Product Overview 19
Brain Mapping Device 20
Brain Mapping Device Product Overview 20
Conventional Pegged Glenoid 21
Conventional Pegged Glenoid Product Overview 21
Cranial Access Kit 22
Cranial Access Kit Product Overview 22
Critical Care Neuro Monitoring System 23
Critical Care Neuro Monitoring System Product Overview 23
CUSA Ultrasonic Tissue Ablation System - Liver 24
CUSA Ultrasonic Tissue Ablation System - Liver Product Overview 24
eDISC 25
eDISC Product Overview 25
Hydrocephalic Shunt 26
Hydrocephalic Shunt Product Overview 26
Injectable Dermal Filler 27
Injectable Dermal Filler Product Overview 27
Integra Nextgen Nerve 28
Integra Nextgen Nerve Product Overview 28
La Jolla 29
La Jolla Product Overview 29
MAYFIELD Composite 30
MAYFIELD Composite Product Overview 30
Next Generation DuraSeal 31
Next Generation DuraSeal Product Overview 31
PyroCarbon Hemi Shoulder 32
PyroCarbon Hemi Shoulder Product Overview 32
Pyrocarbon HRA 33
Pyrocarbon HRA Product Overview 33
Pyrocarbon Modular Radial Head 34
Pyrocarbon Modular Radial Head Product Overview 34
Stereotaxy Device 35
Stereotaxy Device Product Overview 35
Ventricular Drainage Device 36
Ventricular Drainage Device Product Overview 36
Integra LifeSciences Holdings Corp - Key Competitors 37
Integra LifeSciences Holdings Corp - Key Employees 38
Integra LifeSciences Holdings Corp - Key Employee Biographies 39
Integra LifeSciences Holdings Corp - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 44
Integra LifeSciences Holdings Corp, Recent Developments 44
Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 44
Mar 28, 2017: Integra LifeSciences Announces Commercial Expansion of the Cadence Total Ankle System 45
Mar 16, 2017: Integra LifeSciences Introduces Next Generation CUSA Clarity Ultrasonic Tissue Ablation System 45
Mar 15, 2017: Integra LifeSciences Launches Press-Fit Reverse Shoulder for Fracture for the Titan Modular Shoulder System 46
Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 46
Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 47
Dec 05, 2016: Integra LifeSciences announces management changes 48
Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 48
Oct 17, 2016: Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for PriMatrix Dermal Repair Scaffold at Symposium on Advanced Wound Care Fall Meeting 49
Oct 17, 2016: Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft Dermal Regeneration Matrix at Symposium on Advanced Wound Care Fall Meeting 50
Appendix 51
Methodology 51
About GlobalData 53
Contact Us 53
Disclaimer 53

List Of Tables


Integra LifeSciences Holdings Corp Pipeline Products and Ongoing Clinical Trials Overview 6
Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type 7
Integra LifeSciences Holdings Corp Pipeline Products by Indication 8
Integra LifeSciences Holdings Corp, Key Facts 9
Integra LifeSciences Holdings Corp, Major Products and Services 10
Integra LifeSciences Holdings Corp Number of Pipeline Products by Development Stage 13
Integra LifeSciences Holdings Corp Pipeline Products Summary by Development Stage 14
2-Piece Total Ankle Replacement System - Product Status 15
2-Piece Total Ankle Replacement System - Product Description 15
Abdominal Wall Matrix - Product Status 16
Abdominal Wall Matrix - Product Description 16
Advanced Glenoid Platform - Product Status 17
Advanced Glenoid Platform - Product Description 17
Advanced Shoulder System - Product Status 18
Advanced Shoulder System - Product Description 18
Biologic Vascular Graft - Product Status 19
Biologic Vascular Graft - Product Description 19
Brain Mapping Device - Product Status 20
Brain Mapping Device - Product Description 20
Conventional Pegged Glenoid - Product Status 21
Conventional Pegged Glenoid - Product Description 21
Cranial Access Kit - Product Status 22
Cranial Access Kit - Product Description 22
Critical Care Neuro Monitoring System - Product Status 23
Critical Care Neuro Monitoring System - Product Description 23
CUSA Ultrasonic Tissue Ablation System - Liver - Product Status 24
CUSA Ultrasonic Tissue Ablation System - Liver - Product Description 24
eDISC - Product Status 25
eDISC - Product Description 25
Hydrocephalic Shunt - Product Status 26
Hydrocephalic Shunt - Product Description 26
Injectable Dermal Filler - Product Status 27
Injectable Dermal Filler - Product Description 27
Integra Nextgen Nerve - Product Status 28
Integra Nextgen Nerve - Product Description 28
La Jolla - Product Status 29
La Jolla - Product Description 29
MAYFIELD Composite - Product Status 30
MAYFIELD Composite - Product Description 30
Next Generation DuraSeal - Product Status 31
Next Generation DuraSeal - Product Description 31
PyroCarbon Hemi Shoulder - Product Status 32
PyroCarbon Hemi Shoulder - Product Description 32
Pyrocarbon HRA - Product Status 33
Pyrocarbon HRA - Product Description 33
Pyrocarbon Modular Radial Head - Product Status 34
Pyrocarbon Modular Radial Head - Product Description 34
Stereotaxy Device - Product Status 35
Stereotaxy Device - Product Description 35
Ventricular Drainage Device - Product Status 36
Ventricular Drainage Device - Product Description 36
Integra LifeSciences Holdings Corp, Key Employees 38
Integra LifeSciences Holdings Corp, Key Employee Biographies 39
Integra LifeSciences Holdings Corp, Other Locations 40
Integra LifeSciences Holdings Corp, Subsidiaries 40
Glossary 52

List Of Figures


Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type 7
Integra LifeSciences Holdings Corp Pipeline Products by Development Stage 13

Global Ambulatory Surgical Center Operating Room Integration Systems Market 2023

The global laparoscopy and endoscopy devices market is valued at $24.49 billion in 2022 and is projected to reach $31.79 billion by 2029, growing at a CAGR of 3.7% from

USD 2750 View Report

Global Orally Disintegrating Tablets Market Research Report 2021-2025

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Orally Disintegrating Tablets Report by Material, Application, and

USD 3200 View Report

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Integra LifeSciences Holdings Corp (IART) - Product Pipeline Analysis, 2020 Update

Integra LifeSciences Holdings Corp (Integra) is a medical technology company that offers engineered collagen-based product lines. The companys portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available